In mice, tuberculosis progression is associated with intensive inflammatory response and the accumulation of Gr-1 cells in the lungs
- PMID: 20454613
- PMCID: PMC2864263
- DOI: 10.1371/journal.pone.0010469
In mice, tuberculosis progression is associated with intensive inflammatory response and the accumulation of Gr-1 cells in the lungs
Abstract
Background: Infection with Mycobacterium tuberculosis (Mtb) results in different clinical outcomes ranging from asymptomatic containment to rapidly progressing tuberculosis (TB). The mechanisms controlling TB progression in immunologically-competent hosts remain unclear.
Methodology/principal findings: To address these mechanisms, we analyzed TB progression in a panel of genetically heterogeneous (A/SnxI/St) F2 mice, originating from TB-highly-susceptible I/St and more resistant A/Sn mice. In F2 mice the rates of TB progression differed. In mice that did not reach terminal stage of infection, TB progression did not correlate with lung Mtb loads. Nor was TB progression correlated with lung expression of factors involved in antibacterial immunity, such as iNOS, IFN-gamma, or IL-12p40. The major characteristics of progressing TB was high lung expression of the inflammation-related factors IL-1beta, IL-6, IL-11 (p<0.0003); CCL3, CCL4, CXCL2 (p<0.002); MMP-8 (p<0.0001). The major predictors of TB progression were high expressions of IL-1beta and IL-11. TNF-alpha had both protective and harmful effects. Factors associated with TB progression were expressed mainly by macrophages (F4-80(+) cells) and granulocytes (Gr-1(hi)/Ly-6G(hi) cells). Macrophages and granulocytes from I/St and A/Sn parental strains exhibited intrinsic differences in the expression of inflammatory factors, suggesting that genetically determined peculiarities of phagocytes transcriptional response could account for the peculiarities of gene expression in the infected lungs. Another characteristic feature of progressing TB was the accumulation in the infected lungs of Gr-1(dim) cells that could contribute to TB progression.
Conclusions/significance: In a population of immunocompetent hosts, the outcome of TB depends on quantitatively- and genetically-controlled differences in the intensity of inflammatory responses, rather than being a direct consequence of mycobacterial colonization. Local accumulation of Gr-1(dim) cells is a newly identified feature of progressing TB. High expression of IL-1beta and IL-11 are potential risk factors for TB progression and possible targets for TB immunomodulation.
Conflict of interest statement
Figures








Similar articles
-
A new model for chronic and reactivation tuberculosis: Infection with genetically attenuated Mycobacterium tuberculosis in mice with polar susceptibility.Tuberculosis (Edinb). 2018 Dec;113:130-138. doi: 10.1016/j.tube.2018.10.003. Epub 2018 Oct 10. Tuberculosis (Edinb). 2018. PMID: 30514495
-
Comparative analysis of T lymphocytes recovered from the lungs of mice genetically susceptible, resistant, and hyperresistant to Mycobacterium tuberculosis-triggered disease.J Immunol. 2000 Nov 15;165(10):5921-31. doi: 10.4049/jimmunol.165.10.5921. J Immunol. 2000. PMID: 11067954
-
Gr-1dimCD11b+ immature myeloid-derived suppressor cells but not neutrophils are markers of lethal tuberculosis infection in mice.J Immunol. 2014 May 15;192(10):4718-27. doi: 10.4049/jimmunol.1301365. Epub 2014 Apr 7. J Immunol. 2014. PMID: 24711621 Free PMC article.
-
[Development of antituberculous drugs: current status and future prospects].Kekkaku. 2006 Dec;81(12):753-74. Kekkaku. 2006. PMID: 17240921 Review. Japanese.
-
Natural and trained innate immunity against Mycobacterium tuberculosis.Immunobiology. 2020 May;225(3):151951. doi: 10.1016/j.imbio.2020.151951. Epub 2020 Apr 27. Immunobiology. 2020. PMID: 32423788 Review.
Cited by
-
Recombinant BCG expressing the LTAK63 adjuvant improves a short-term chemotherapy schedule in the control of tuberculosis in mice.Front Immunol. 2022 Aug 31;13:943558. doi: 10.3389/fimmu.2022.943558. eCollection 2022. Front Immunol. 2022. PMID: 36119106 Free PMC article.
-
An interferon-related signature in the transcriptional core response of human macrophages to Mycobacterium tuberculosis infection.PLoS One. 2012;7(6):e38367. doi: 10.1371/journal.pone.0038367. Epub 2012 Jun 4. PLoS One. 2012. PMID: 22675550 Free PMC article.
-
LncRNA CCAT1 is overexpressed in tuberculosis patients and predicts their survival.Immun Inflamm Dis. 2022 Feb;10(2):218-224. doi: 10.1002/iid3.565. Epub 2021 Nov 30. Immun Inflamm Dis. 2022. PMID: 34847295 Free PMC article.
-
Prime-boost bacillus Calmette-Guérin vaccination with lentivirus-vectored and DNA-based vaccines expressing antigens Ag85B and Rv3425 improves protective efficacy against Mycobacterium tuberculosis in mice.Immunology. 2014 Oct;143(2):277-86. doi: 10.1111/imm.12308. Immunology. 2014. PMID: 24773322 Free PMC article.
-
Host genome polymorphisms and tuberculosis infection: What we have to say?Egypt J Chest Dis Tuberc. 2014 Jan;63(1):173-185. doi: 10.1016/j.ejcdt.2013.12.002. Epub 2013 Dec 17. Egypt J Chest Dis Tuberc. 2014. PMID: 26966339 Free PMC article.
References
-
- Raviglione MC. The TB epidemic from 1992 to 2002. Tuberculosis (Edinb) 2003;83:4–14. - PubMed
-
- Bellamy R, Hill AVS. Host genetic susceptibility to human tuberculosis. Novartis Foundation Symposium. 1998;217:3–23. - PubMed
-
- Dietrich WF. Using mouse genetics to understand infectious disease pathogenesis. Genome Res. 2001;11:325–331. - PubMed
-
- Flynn JL, Ernst JD. Immune responses in tuberculosis. Curr Opin Immunol. 2000;12:432–436. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous